您当前的位置：
首页 >
文章列表页 >
Research progress of an immune checkpoint molecule VISTA in hematological tumors
Medical Journal of Chinese People′s Liberation Army   Vol. 50, Issue 6, Pages: 672-678(2025)
Special Issue on Mechanisms, Targeting, and Treatment Strategies of Tumor Immunotherapy | 更新时间：2025-07-10

    • Research progress of an immune checkpoint molecule VISTA in hematological tumors

    • “VISTA, as an emerging immune checkpoint molecule, plays an important role in the treatment of hematological tumors and provides a new target for overcoming immune therapy resistance.”

    • DOI：10.11855/j.issn.0577-7402.1065.2025.0123    

      CLC： R733

    • Received：16 July 2024，

      Accepted：26 October 2024，

      Published：28 June 2025

    移动端阅览

  • Tang Zi-Jun,Zheng Han-Xue,Xiong Hao,et al.Research progress of an immune checkpoint molecule VISTA in hematological tumors[J].Medical Journal of Chinese People′s Liberation Army,2025,50(06):672-678. DOI： 10.11855/j.issn.0577-7402.1065.2025.0123.

  •  
  •  

0

Views

0

下载量

0

CSCD

0

CNKI被引量

>
Alert me when the article has been cited
提交
Outline
No Sections

Related Articles

Treatment of non-small cell lung cancer comes to the age of immunotherapy
Research progress on the role of NF-κB signaling pathway in drug resistance mechanisms of pancreatic cancer
Research progress of neoantigens in tumor immunotherapy

Related Author

Li Li-Juan
YUAN Dong-mei
SONG Yong
Shu Ya-Ting
Peng Mei-Yu
Liu Mei-Fang
Cui Zhao
Lei Fan

Related Institution

Department of Respiratory Medicine, General Hospital of Nanjing Command
Key Laboratory of Immune Microenvironment and Inflammatory Disease Research in Universities of Shandong Province/Immunology Laboratory of Shandong Second Medical University
Department of Research, the Second Affiliated Hospital of Xi`an Medical University
Department of Tumor Surgery, the Second Hospital of Lanzhou University
Gansu Provincial Key Laboratory of Gastrointestinal Tumors
0